SalvaRx Group PLC logo

SalvaRx Group PLC

Europe, Cambridgeshire, United Kingdom, Ramsey

Description

SalvaRx Group PLC is a drug discovery and development company focused on immune-oncology & invests in novel cancer immune-therapies.

Investor Profile

SalvaRx Group PLC has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Therapeutics.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SalvaRx Group PLC frequently co-invest with?

Batterson Venture Capital
North America, Illinois, United States, Chicago
Co-Investments: 1
VCapital
North America, Illinois, United States, Chicago
Co-Investments: 1

Which angels does SalvaRx Group PLC often collaborate with?

JM
Europe, Isle of Man
Shared Deals: 1
DD
Europe, NA - Isle of Man, Isle of Man, Douglas
Shared Deals: 1

What are some of recent deals done by SalvaRx Group PLC?

Intensity Therapeutics

Norwalk, Connecticut, United States

Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.

BiopharmaBiotechnologyTherapeutics
Series AJun 28, 2016
Amount Raised: $10,000,000

Find More Investors Like SalvaRx Group PLC

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

SalvaRx Group PLC | Pipeseed